Selected research
Industry Research
Intravenous Drug Delivery Devices Industry Research Report 2026
Market perspective
The global Intravenous Drug Delivery Devices market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Intravenous Drug Delivery Devices is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Intravenous Drug Delivery Devices is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Intravenous Drug Delivery Devices is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Intravenous Drug Delivery Devices include Johnson & Johnson, Novartis, Pfizer, Teva Pharmaceuticals, Schott, Novo Nordisk, Insulet Corporation, Gerresheimer and Eli Lilly and Company, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Intravenous Drug Delivery Devices market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Intravenous Drug Delivery Devices Market by Company
Johnson & Johnson
Novartis
Pfizer
Teva Pharmaceuticals
Schott
Novo Nordisk
Insulet Corporation
Gerresheimer
Eli Lilly and Company
Cardinal Health
Becton Dickinson and Company
Baxter International
B. Braun Melsungen AG
Intravenous Drug Delivery Devices Segment by Type
Auto-injectors (Syringe and Cartridge Based)
Pen Injectors
Others
Intravenous Drug Delivery Devices Segment by Application
Home Care
Nursing Homes
Hospitals
Others
Intravenous Drug Delivery Devices Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Drug Delivery Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Intravenous Drug Delivery Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Drug Delivery Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Intravenous Drug Delivery Devices manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Intravenous Drug Delivery Devices by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Intravenous Drug Delivery Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Auto-injectors (Syringe and Cartridge Based)
- Pen Injectors
- Others
Applications
- Home Care
- Nursing Homes
- Hospitals
- Others
Companies covered
- Johnson & Johnson
- Novartis
- Pfizer
- Teva Pharmaceuticals
- Schott
- Novo Nordisk
- Insulet Corporation
- Gerresheimer
- Eli Lilly and Company
- Cardinal Health
- Becton Dickinson and Company
- Baxter International
- B. Braun Melsungen AG
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Intravenous Drug Delivery Devices Market Size (2021-2032)
- 2.2.2 Global Intravenous Drug Delivery Devices Sales (2021-2032)
- 2.2.3 Global Intravenous Drug Delivery Devices Market Average Price (2021-2032)
- 2.3 Intravenous Drug Delivery Devices by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Auto-injectors (Syringe and Cartridge Based)
- 2.3.3 Pen Injectors
- 2.3.4 Others
- 2.4 Intravenous Drug Delivery Devices by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Home Care
- 2.4.3 Nursing Homes
- 2.4.4 Hospitals
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Intravenous Drug Delivery Devices Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Intravenous Drug Delivery Devices Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Intravenous Drug Delivery Devices Revenue of Manufacturers (2021-2026)
- 3.4 Global Intravenous Drug Delivery Devices Average Price by Manufacturers (2021-2026)
- 3.5 Global Intravenous Drug Delivery Devices Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Intravenous Drug Delivery Devices, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Intravenous Drug Delivery Devices, Product Type & Application
- 3.8 Global Manufacturers of Intravenous Drug Delivery Devices, Established Date
- 3.9 Global Intravenous Drug Delivery Devices Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Johnson & Johnson
- 4.1.1 Johnson & Johnson Company Information
- 4.1.2 Johnson & Johnson Business Overview
- 4.1.3 Johnson & Johnson Intravenous Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Johnson & Johnson Intravenous Drug Delivery Devices Product Portfolio
- 4.1.5 Johnson & Johnson Recent Developments
- 4.2 Novartis
- 4.2.1 Novartis Company Information
- 4.2.2 Novartis Business Overview
- 4.2.3 Novartis Intravenous Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Novartis Intravenous Drug Delivery Devices Product Portfolio
- 4.2.5 Novartis Recent Developments
- 4.3 Pfizer
- 4.3.1 Pfizer Company Information
- 4.3.2 Pfizer Business Overview
- 4.3.3 Pfizer Intravenous Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pfizer Intravenous Drug Delivery Devices Product Portfolio
- 4.3.5 Pfizer Recent Developments
- 4.4 Teva Pharmaceuticals
- 4.4.1 Teva Pharmaceuticals Company Information
- 4.4.2 Teva Pharmaceuticals Business Overview
- 4.4.3 Teva Pharmaceuticals Intravenous Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Teva Pharmaceuticals Intravenous Drug Delivery Devices Product Portfolio
- 4.4.5 Teva Pharmaceuticals Recent Developments
- 4.5 Schott
- 4.5.1 Schott Company Information
- 4.5.2 Schott Business Overview
- 4.5.3 Schott Intravenous Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Schott Intravenous Drug Delivery Devices Product Portfolio
- 4.5.5 Schott Recent Developments
- 4.6 Novo Nordisk
- 4.6.1 Novo Nordisk Company Information
- 4.6.2 Novo Nordisk Business Overview
- 4.6.3 Novo Nordisk Intravenous Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Novo Nordisk Intravenous Drug Delivery Devices Product Portfolio
- 4.6.5 Novo Nordisk Recent Developments
- 4.7 Insulet Corporation
- 4.7.1 Insulet Corporation Company Information
- 4.7.2 Insulet Corporation Business Overview
- 4.7.3 Insulet Corporation Intravenous Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Insulet Corporation Intravenous Drug Delivery Devices Product Portfolio
- 4.7.5 Insulet Corporation Recent Developments
- 4.8 Gerresheimer
- 4.8.1 Gerresheimer Company Information
- 4.8.2 Gerresheimer Business Overview
- 4.8.3 Gerresheimer Intravenous Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Gerresheimer Intravenous Drug Delivery Devices Product Portfolio
- 4.8.5 Gerresheimer Recent Developments
- 4.9 Eli Lilly and Company
- 4.9.1 Eli Lilly and Company Company Information
- 4.9.2 Eli Lilly and Company Business Overview
- 4.9.3 Eli Lilly and Company Intravenous Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Eli Lilly and Company Intravenous Drug Delivery Devices Product Portfolio
- 4.9.5 Eli Lilly and Company Recent Developments
- 4.10 Cardinal Health
- 4.10.1 Cardinal Health Company Information
- 4.10.2 Cardinal Health Business Overview
- 4.10.3 Cardinal Health Intravenous Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Cardinal Health Intravenous Drug Delivery Devices Product Portfolio
- 4.10.5 Cardinal Health Recent Developments
- 4.11 Becton Dickinson and Company
- 4.11.1 Becton Dickinson and Company Company Information
- 4.11.2 Becton Dickinson and Company Business Overview
- 4.11.3 Becton Dickinson and Company Intravenous Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Becton Dickinson and Company Intravenous Drug Delivery Devices Product Portfolio
- 4.11.5 Becton Dickinson and Company Recent Developments
- 4.12 Baxter International
- 4.12.1 Baxter International Company Information
- 4.12.2 Baxter International Business Overview
- 4.12.3 Baxter International Intravenous Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Baxter International Intravenous Drug Delivery Devices Product Portfolio
- 4.12.5 Baxter International Recent Developments
- 4.13 B. Braun Melsungen AG
- 4.13.1 B. Braun Melsungen AG Company Information
- 4.13.2 B. Braun Melsungen AG Business Overview
- 4.13.3 B. Braun Melsungen AG Intravenous Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 B. Braun Melsungen AG Intravenous Drug Delivery Devices Product Portfolio
- 4.13.5 B. Braun Melsungen AG Recent Developments
5 Global Intravenous Drug Delivery Devices Market Scenario by Region
- 5.1 Global Intravenous Drug Delivery Devices Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Intravenous Drug Delivery Devices Sales by Region: 2021-2032
- 5.2.1 Global Intravenous Drug Delivery Devices Sales by Region: 2021-2026
- 5.2.2 Global Intravenous Drug Delivery Devices Sales by Region: 2027-2032
- 5.3 Global Intravenous Drug Delivery Devices Revenue by Region: 2021-2032
- 5.3.1 Global Intravenous Drug Delivery Devices Revenue by Region: 2021-2026
- 5.3.2 Global Intravenous Drug Delivery Devices Revenue by Region: 2027-2032
- 5.4 North America Intravenous Drug Delivery Devices Market Facts & Figures by Country
- 5.4.1 North America Intravenous Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Intravenous Drug Delivery Devices Sales by Country (2021-2032)
- 5.4.3 North America Intravenous Drug Delivery Devices Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Intravenous Drug Delivery Devices Market Facts & Figures by Country
- 5.5.1 Europe Intravenous Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Intravenous Drug Delivery Devices Sales by Country (2021-2032)
- 5.5.3 Europe Intravenous Drug Delivery Devices Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Intravenous Drug Delivery Devices Market Facts & Figures by Country
- 5.6.1 Asia Pacific Intravenous Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Intravenous Drug Delivery Devices Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Intravenous Drug Delivery Devices Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Intravenous Drug Delivery Devices Market Facts & Figures by Country
- 5.7.1 South America Intravenous Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Intravenous Drug Delivery Devices Sales by Country (2021-2032)
- 5.7.3 South America Intravenous Drug Delivery Devices Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Intravenous Drug Delivery Devices Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Intravenous Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Intravenous Drug Delivery Devices Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Intravenous Drug Delivery Devices Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Intravenous Drug Delivery Devices Sales by Type (2021-2032)
- 6.1.1 Global Intravenous Drug Delivery Devices Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Intravenous Drug Delivery Devices Sales Market Share by Type (2021-2032)
- 6.2 Global Intravenous Drug Delivery Devices Revenue by Type (2021-2032)
- 6.2.1 Global Intravenous Drug Delivery Devices Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Intravenous Drug Delivery Devices Revenue Market Share by Type (2021-2032)
- 6.3 Global Intravenous Drug Delivery Devices Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Intravenous Drug Delivery Devices Sales by Application (2021-2032)
- 7.1.1 Global Intravenous Drug Delivery Devices Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Intravenous Drug Delivery Devices Sales Market Share by Application (2021-2032)
- 7.2 Global Intravenous Drug Delivery Devices Revenue by Application (2021-2032)
- 7.2.1 Global Intravenous Drug Delivery Devices Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Intravenous Drug Delivery Devices Revenue Market Share by Application (2021-2032)
- 7.3 Global Intravenous Drug Delivery Devices Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Intravenous Drug Delivery Devices Value Chain Analysis
- 8.1.1 Intravenous Drug Delivery Devices Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Intravenous Drug Delivery Devices Production Mode & Process
- 8.2 Intravenous Drug Delivery Devices Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Intravenous Drug Delivery Devices Distributors
- 8.2.3 Intravenous Drug Delivery Devices Customers
9 Global Intravenous Drug Delivery Devices Analyzing Market Dynamics
- 9.1 Intravenous Drug Delivery Devices Industry Trends
- 9.2 Intravenous Drug Delivery Devices Industry Drivers
- 9.3 Intravenous Drug Delivery Devices Industry Opportunities and Challenges
- 9.4 Intravenous Drug Delivery Devices Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst